Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other Jan 29, 2013 | not rated yet | 0
(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.
Other Jan 23, 2013 | not rated yet | 0
Higher sales of prescription drugs and medical devices helped Johnson & Johnson post a much bigger fourth-quarter profit than a year ago, when a slew of charges depressed results.
Other Jan 22, 2013 | not rated yet | 0
If tobacco products sold in the UK were subject to price cap regulation, the system would generate around £500 million (US$750 million) for the government every year, without affecting the price consumers pay, reveals a ...
Health Jan 14, 2013 | not rated yet | 0
You may have to be over a certain age to be a contestant on "Deal or No Deal", but children as young as five start to maximize their profits - in cookies - when making decisions similar to those on the show, according to ...
Psychology & Psychiatry Jan 09, 2013 | not rated yet | 0 |
(HealthDay)—Physician business models are transforming, with a sustained shift away from independent practice, according to report released by the consulting firm Accenture.
Health Dec 11, 2012 | not rated yet | 0
(HealthDay)—Implementation of a series of national-scale pilot programs designed to increase the access and use of quality-assured artemisinin-based combination therapies (QAACTs) for malaria by the Affordable ...
Diseases, Conditions, Syndromes Nov 01, 2012 | not rated yet | 0
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Other Nov 01, 2012 | not rated yet | 0
Addressing the obesity epidemic by preventing excess calorie consumption with government regulation of portion sizes is justifiable and could be an effective measure to help prevent obesity-related health problems and deaths, ...
Overweight and Obesity Sep 18, 2012 | not rated yet | 0
(AP) Danish pharmaceutical company Novo Nordisk A/S says its net profit grew by 29 percent in the second quarter of 2012, chiefly spurred by strong sales of its new diabetes drugs.
Other Aug 09, 2012 | not rated yet | 0
Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.
Other Jul 27, 2012 | not rated yet | 0
British drugmaker GlaxoSmithKline on Wednesday said its second quarter net profit rose 13.3 percent from a year earlier to £1.25 billion ($1.94 billion, 1.59 billion euros).
Other Jul 25, 2012 | not rated yet | 0
Drug manufacturers and the Food and Drug Administration (FDA) scrambled earlier this month to address a sudden shortage of methotrexate, a 60-year-old drug that treats children with severe cases of leukemia ...
Medications Feb 28, 2012 | not rated yet | 0
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rose seven percent, boosted by growth across its main pharmaceuticals, vaccines and consumer healthcare divisions.
Other Oct 26, 2011 | 5 / 5 (1) | 1
Swiss pharmaceutical giant Novartis announced 2,000 job losses Tuesday, mostly in Switzerland and the United States, while reporting net profits of $3.53 billion (2.5 billion euros) for the third quarter.
Other Oct 25, 2011 | 5 / 5 (1) | 0